A Plus Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	May '26 May 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2,470	2,956	2,444	1,380	-	-
Market Cap Growth	-24.60%	20.95%	77.04%	-	-	-
Enterprise Value	2,024	2,465	2,205	1,246	-	-
Last Close Price	73.30	80.47	72.81	39.88	-	-
PE Ratio	14.30	17.45	16.18	-	-	-
PS Ratio	2.88	3.54	3.18	2.05	-	-
PB Ratio	2.16	2.34	2.66	1.67	-	-
P/TBV Ratio	2.17	2.35	2.68	1.68	-	-
P/FCF Ratio	111.36	20.41	16.07	9.22	-	-
P/OCF Ratio	15.61	18.60	15.18	8.68	-	-
EV/Sales Ratio	2.36	2.95	2.87	1.85	-	-
EV/EBITDA Ratio	8.35	10.96	11.17	6.87	-	-
EV/EBIT Ratio	9.35	11.81	12.08	7.44	-	-
EV/FCF Ratio	91.26	17.02	14.50	8.32	-	-
Debt / Equity Ratio	0.14	0.08	0.12	0.14	0.24	0.05
Debt / EBITDA Ratio	0.70	0.41	0.52	0.59	3.01	0.57
Debt / FCF Ratio	7.37	0.66	0.70	0.76	-	0.36
Net Debt / Equity Ratio	-0.39	-0.40	-0.31	-0.25	-0.12	-0.33
Net Debt / EBITDA Ratio	-1.99	-2.28	-1.44	-1.14	-1.48	-3.70
Net Debt / FCF Ratio	-20.24	-3.54	-1.87	-1.38	0.60	-2.34
Asset Turnover	0.59	0.61	0.68	-	0.51	-
Inventory Turnover	0.84	0.82	0.82	-	0.68	-
Quick Ratio	2.08	3.97	3.52	3.24	2.18	2.77
Current Ratio	3.16	5.99	5.49	5.39	3.74	4.64
Return on Equity (ROE)	17.46%	15.52%	17.29%	-	4.41%	-
Return on Assets (ROA)	8.94%	9.57%	10.14%	-	2.73%	-
Return on Invested Capital (ROIC)	22.57%	23.59%	23.39%	-91.37%	5.72%	6.68%
Return on Capital Employed (ROCE)	16.00%	15.40%	18.00%	18.00%	4.70%	5.50%
Earnings Yield	7.01%	5.73%	6.18%	-0.82%	-	-
FCF Yield	0.90%	4.90%	6.22%	10.85%	-	-
Dividend Yield	6.82%	6.21%	5.49%	6.77%	-	-
Payout Ratio	70.35%	71.96%	53.95%	-	43.48%	-
Buyback Yield / Dilution	-11.14%	-8.36%	-0.37%	-4.70%	-0.95%	-
Total Shareholder Return	-4.31%	-2.15%	5.12%	2.07%	-0.95%	-